342
Participants
Start Date
March 31, 2003
Primary Completion Date
May 31, 2005
Study Completion Date
May 31, 2005
Myfortic
National Taiwan University Hospital, Taipei
Chang-Gung Memorial Hospital-Linko, Taoyuan District
Crai Norte, San Martín
Royal Prince Alfred Hospital, Camperdown
Royal Melbourne Hospital, Parkville
Monash Medical Centre, Clayton
Princess Alexandra Hospital, Woolloongabba
Hospital Cordoba, Córdoba
The Queen Elizabeth Hospital, Woodville
Hospital Clinico San Carlos, Madrid
Hospital Central de Asturias, Oviedo
Livelink, Inc., Tampa
Ohio State University Medical Center, Columbus
University Hospitals of Cleveland, Division of Nephrology, Cleveland
Indiana U. Medical Center, Indianapolis
University of Michigan Health System, Ann Arbor
Hospital Kuala Lumpur, Kuala Lumpur
Staedt. Krankenhaus Koeln-Merheim, Cologne
Loyola Medical Center, Maywood
Klinikum der Johann Wolfgang Geothe-Universitaet, Frankfurt am Main
Ospedale Consorziale e policlinico-Universita degli Studi, Bari
Legacy Research & Technology Ctr., Portland
Singapore General Hospital, Singapore
UCSF Kidney Transplant Service, San Francisco
U. of Wisconsin Hospital Clinics, Madison
Unidad de Transplante Velez Sarsfield, Córdoba
Hospital das Clinicas - UNICAMP, Campinas
Hipertensao Hospital do Rim e Hipertensao, São Paulo
Foothills Medical Center, Calgary
University of Alberta Hospital, Edmonton
Queen II Health and Science Center, Halifax
St. Michael's Hospital, Toronto
University Health Network, The Toronto Hospital, Toronto
McGill University Health Centre, Montreal
Royal University Hospital, Saskatoon
Auckland Hospital, Auckland
Taipei Veterans General Hospital, Taipei
Hospital de Bellvitge, L'Hospitalet de Llobregat
Queen Elizabeth Medical Centre, Edgbaston
University Hospital of Wales, Heathpark
Walsgrave Hospital NHS Trust, Walsgrave on Sowe
Freeman Hospital, High Heaton
Guy's Hospital, London
Nottingham City Hospital, Nottingham
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY